logo

In The Spotlight

Share

ipo-july16.jpg The IPO activity in the U.S. pharma/biotech sector had a strong showing last quarter (Q2) with 24 listings compared to 13 in the year-ago period. There has not been a single biotech IPO for the month of July so far. But that is about to change.

pharma-daily-071018.jpg Shares of Ra Pharmaceuticals Inc. (RARX) are up nearly 22% so far this month compared to the 8.5% gain of the iShares Nasdaq Biotechnology ETF (IBB) index during the same period.

zafgen-july6.jpg Shares of Zafgen Inc. (ZFGN) are up an impressive 129% year-to-date compared to the 4% gain of the iShares Nasdaq Biotechnology ETF (IBB) index during the same period.

transenterix-june28.jpg Shares of medical device company TransEnterix Inc. (TRXC) are up more than 200% year-to-date.

sangamobuilding-june21.jpg Shares of Sangamo Therapeutics Inc. (SGMO) are down nearly 33% from their 52-week high to $18. Given the fact that the Company has potential clinical data readouts from 7 studies beginning in late summer of this year to 2019, it is worth keeping an eye on this stock.

krystal-june8.jpg Shares of Krystal Biotech Inc. (KRYS) touched a new high of $13.00 on Thursday, and are up 30% since the beginning of this year.

bladdercancer-june1.jpg Shares of Sesen Bio Inc. (SESN) are up more than 37% over the past 3 days while the iShares Nasdaq Biotechnology Index (ETF)(IBB) has gained a mere 1.2% for the same period.

novus-052318.jpg Shares of Novus Therapeutics (NVUS) are up an impressive 47% so far this month while the iShares Nasdaq Biotechnology Index (ETF)(IBB) is up a mere 3% for the same period.

inspire-system-051618.jpg Shares of Inspire Medical Systems Inc. (INSP) have climbed 32% since the Company went public this month.

evolus-may9.jpg Shares of Evolus Inc. (EOLS) are up an impressive 38% so far this month while the iShares Nasdaq Biotechnology Index (ETF)(IBB) is down 1% for the same period.

eloxx-050318.jpg Shares of Eloxx Pharmaceuticals Inc. (ELOX) have gained an impressive 65% so far this year while the iShares NASDAQ Biotechnology Index (ETF)(IBB) is down 4.5% during the same period.

Follow RTT